Cyndeo Wealth Partners, LLC
Position in HURA — TuHURA Biosciences, Inc./NV
CIK 1950947
ST. PETERSBURG, FL
Position in HURA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$24,867
+$5,845 QoQ
Shares Held
10,627
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 90 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cyndeo Wealth Partners, LLC holds $5,325,846 across 6 Biotechnology names. HURA ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 118,444 | $3,722,694 | |||
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
25,430 | $430,275 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
676 | $421,513 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
6,978 | $380,580 | |
| 5 | EYPT |
EyePoint, Inc.
|
24,190 | $345,917 | |
| 6 | HURA |
TuHURA Biosciences, Inc./NV
This page
|
10,627 | $24,867 |
All Filings in HURA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,867 | 10,627 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $19,022 | 10,627 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $23,514 | 31,063 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $77,036 | 31,063 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $23,698 | 10,627 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $34,325 | 10,627 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $43,464 | 10,627 | Shares | Sole | 2025-01-21 | |
| No filing history on record for this holder in this stock. | ||||||